FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2030996923> ?p ?o ?g. }

• W2030996923 endingPage "636" @default.
• W2030996923 startingPage "632" @default.
• W2030996923 abstract "►Ezetimibe-plus-statin therapy enhances low-density lipoprotein (LDL) receptor activity. ►It is still unclear whether ezetimibe alone enhances LDL receptor activity. ►Patients with hypercholesterolemia were treated with ezetimibe for 4 months. ►LDL receptor activities were estimated with the equation during the therapy. ►Ezetimibe lowered LDL cholesterol without raising LDL receptor activity. Background Ezetimibe, an inhibitor of intestinal cholesterol absorption, is effective in lowering serum low-density lipoprotein (LDL) cholesterol with or without coadministration of statin. Ezetimibe-plus-statin therapy enhances LDL receptor activity, but it is still unclear whether ezetimibe alone enhances LDL receptor activity, resulting in LDL cholesterol decrease. Objective We investigated whether ezetimibe lowers serum LDL cholesterol by raising LDL receptor activity in humans. Methods Patients with hypercholesterolemia (n = 28; age [mean ± SD], 61.6 ± 13.0 years; 57% men) were treated with ezetimibe (10 mg/d) for 4 months. Before and after the treatment, serum LDL cholesterol, apolipoprotein B (apo B), and apolipoprotein C-II (apo C-II) were measured. LDL receptor activities were estimated with the equation we reported previously as follows: LDL receptor activity (represented as a percentage of normocholesterolemic subjects) = 63.595 + apo C-II (in mg/dL) × 13.459−apo B (in mg/dL) × 0.366. Results By the treatment of ezetimibe, LDL cholesterol (176.8 ± 17.9 vs 138.0 ± 19.7 mg/dL) was lowered 21.9% significantly (P < .01). The estimated LDL receptor activities before and after the ezetimibe treatment were 86.8% ± 21.4% and 89.6% ± 19.7%, respectively, with no significant difference between them (P = .13). Conclusion Ezetimibe lowered LDL cholesterol significantly in patients with hypercholesterolemia without raising LDL receptor activity. The enhancement of LDL receptor activity is less involved in the pharmacologic action of ezetimibe. Ezetimibe, an inhibitor of intestinal cholesterol absorption, is effective in lowering serum low-density lipoprotein (LDL) cholesterol with or without coadministration of statin. Ezetimibe-plus-statin therapy enhances LDL receptor activity, but it is still unclear whether ezetimibe alone enhances LDL receptor activity, resulting in LDL cholesterol decrease. We investigated whether ezetimibe lowers serum LDL cholesterol by raising LDL receptor activity in humans. Patients with hypercholesterolemia (n = 28; age [mean ± SD], 61.6 ± 13.0 years; 57% men) were treated with ezetimibe (10 mg/d) for 4 months. Before and after the treatment, serum LDL cholesterol, apolipoprotein B (apo B), and apolipoprotein C-II (apo C-II) were measured. LDL receptor activities were estimated with the equation we reported previously as follows: LDL receptor activity (represented as a percentage of normocholesterolemic subjects) = 63.595 + apo C-II (in mg/dL) × 13.459−apo B (in mg/dL) × 0.366. By the treatment of ezetimibe, LDL cholesterol (176.8 ± 17.9 vs 138.0 ± 19.7 mg/dL) was lowered 21.9% significantly (P < .01). The estimated LDL receptor activities before and after the ezetimibe treatment were 86.8% ± 21.4% and 89.6% ± 19.7%, respectively, with no significant difference between them (P = .13). Ezetimibe lowered LDL cholesterol significantly in patients with hypercholesterolemia without raising LDL receptor activity. The enhancement of LDL receptor activity is less involved in the pharmacologic action of ezetimibe." @default.
• W2030996923 created "2016-06-24" @default.
• W2030996923 creator A5014133166 @default.
• W2030996923 creator A5087133197 @default.
• W2030996923 date "2013-11-01" @default.
• W2030996923 modified "2023-10-10" @default.
• W2030996923 title "Lowering LDL cholesterol, but not raising LDL receptor activity, by ezetimibe" @default.
• W2030996923 cites W1951751997 @default.
• W2030996923 cites W1968630986 @default.
• W2030996923 cites W1969474907 @default.
• W2030996923 cites W2008490947 @default.
• W2030996923 cites W2012406449 @default.
• W2030996923 cites W2029158612 @default.
• W2030996923 cites W2044037402 @default.
• W2030996923 cites W2049617335 @default.
• W2030996923 cites W2052992240 @default.
• W2030996923 cites W2068603806 @default.
• W2030996923 cites W2079874135 @default.
• W2030996923 cites W2084744450 @default.
• W2030996923 cites W2095455730 @default.
• W2030996923 cites W2101969945 @default.
• W2030996923 cites W2116404316 @default.
• W2030996923 cites W2120677058 @default.
• W2030996923 cites W2123936150 @default.
• W2030996923 cites W2129970466 @default.
• W2030996923 cites W2146720979 @default.
• W2030996923 cites W2148030627 @default.
• W2030996923 cites W2150824599 @default.
• W2030996923 cites W2163252871 @default.
• W2030996923 cites W2166344883 @default.
• W2030996923 cites W2167045683 @default.
• W2030996923 cites W2168876694 @default.
• W2030996923 cites W2263870924 @default.
• W2030996923 cites W2336893353 @default.
• W2030996923 doi "https://doi.org/10.1016/j.jacl.2013.06.011" @default.
• W2030996923 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24314361" @default.
• W2030996923 hasPublicationYear "2013" @default.
• W2030996923 type Work @default.
• W2030996923 sameAs 2030996923 @default.
• W2030996923 citedByCount "5" @default.
• W2030996923 countsByYear W20309969232017 @default.
• W2030996923 countsByYear W20309969232020 @default.
• W2030996923 countsByYear W20309969232023 @default.
• W2030996923 crossrefType "journal-article" @default.
• W2030996923 hasAuthorship W2030996923A5014133166 @default.
• W2030996923 hasAuthorship W2030996923A5087133197 @default.
• W2030996923 hasConcept C126322002 @default.
• W2030996923 hasConcept C134018914 @default.
• W2030996923 hasConcept C2776839432 @default.
• W2030996923 hasConcept C2778163477 @default.
• W2030996923 hasConcept C2778657065 @default.
• W2030996923 hasConcept C2779120738 @default.
• W2030996923 hasConcept C2780072125 @default.
• W2030996923 hasConcept C43554185 @default.
• W2030996923 hasConcept C62746215 @default.
• W2030996923 hasConcept C71924100 @default.
• W2030996923 hasConcept C98274493 @default.
• W2030996923 hasConceptScore W2030996923C126322002 @default.
• W2030996923 hasConceptScore W2030996923C134018914 @default.
• W2030996923 hasConceptScore W2030996923C2776839432 @default.
• W2030996923 hasConceptScore W2030996923C2778163477 @default.
• W2030996923 hasConceptScore W2030996923C2778657065 @default.
• W2030996923 hasConceptScore W2030996923C2779120738 @default.
• W2030996923 hasConceptScore W2030996923C2780072125 @default.
• W2030996923 hasConceptScore W2030996923C43554185 @default.
• W2030996923 hasConceptScore W2030996923C62746215 @default.
• W2030996923 hasConceptScore W2030996923C71924100 @default.
• W2030996923 hasConceptScore W2030996923C98274493 @default.
• W2030996923 hasIssue "6" @default.
• W2030996923 hasLocation W20309969231 @default.
• W2030996923 hasLocation W20309969232 @default.
• W2030996923 hasOpenAccess W2030996923 @default.
• W2030996923 hasPrimaryLocation W20309969231 @default.
• W2030996923 hasRelatedWork W2606862434 @default.
• W2030996923 hasRelatedWork W2954542779 @default.
• W2030996923 hasRelatedWork W3011177951 @default.
• W2030996923 hasRelatedWork W3091855412 @default.
• W2030996923 hasRelatedWork W3115963836 @default.
• W2030996923 hasRelatedWork W4230938669 @default.
• W2030996923 hasRelatedWork W4236548589 @default.
• W2030996923 hasRelatedWork W4242868341 @default.
• W2030996923 hasRelatedWork W4376848629 @default.
• W2030996923 hasRelatedWork W1965007842 @default.
• W2030996923 hasVolume "7" @default.
• W2030996923 isParatext "false" @default.
• W2030996923 isRetracted "false" @default.
• W2030996923 magId "2030996923" @default.
• W2030996923 workType "article" @default.